{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:11:52Z","timestamp":1777882312280,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["14-15\/19\/Delhi\/NGO-ECD-I"],"award-info":[{"award-number":["14-15\/19\/Delhi\/NGO-ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ECD\/Ad-hoc\/leprosy\/2014-113\/Fy"],"award-info":[{"award-number":["ECD\/Ad-hoc\/leprosy\/2014-113\/Fy"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jgar.2020.09.021","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:39:28Z","timestamp":1602718768000},"page":"275-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India"],"prefix":"10.1016","volume":"23","author":[{"given":"Mallika","family":"Lavania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Darlong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhvi","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Turankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.09.021_bib0005","first-page":"445","article-title":"Global leprosy update, 2017: reducing the disease burden due to leprosy","volume":"93","author":"World Health Organization (WHO)","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jgar.2020.09.021_bib0010","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.06561-11","article-title":"Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients","volume":"50","author":"da Silva Rocha","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.09.021_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.47276\/lr.85.3.177","article-title":"Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending the Leprosy Mission (TLM) hospitals in India","volume":"85","author":"Lavania","year":"2014","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jgar.2020.09.021_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jgar.2017.10.010","article-title":"Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients","volume":"12","author":"Lavania","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2020.09.021_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(05)60888-4","article-title":"Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae","volume":"11","author":"Cambau","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2020.09.021_bib0030","series-title":"A guide for surveillance of antimicrobial resistance in leprosy: 2017 update","author":"World Health Organization (WHO) SEARO","year":"2017"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:08:35Z","timestamp":1777597715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520302526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":6,"alternative-id":["S2213716520302526"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.09.021","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}